Clinical Pharmacology In Drug Development,volume 7,issue 1  (01-2018)

Period of time： 2018年1期

Publisher： John Wiley & Sons Inc

Founded in： 2012

Total resources： 25

E-ISSN： 2160-7648|7|1

ISSN： 2160-763X

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Clinical Pharmacology In Drug Development,volume 7,issue 1

Menu

Issue Information

Clinical Pharmacology In Drug Development,volume 7,issue 1 , Vol. 7, Iss. 1, 2018-01 , pp. 1-4

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Announcement

Clinical Pharmacology In Drug Development,volume 7,issue 1 , Vol. 7, Iss. 1, 2018-01 , pp. 5-5

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Opioid Prescribing: What Are the Numbers?

Clinical Pharmacology In Drug Development,volume 7,issue 1 , Vol. 7, Iss. 1, 2018-01 , pp. 6-8

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects

Clinical Pharmacology In Drug Development,volume 7,issue 1 , Vol. 7, Iss. 1, 2018-01 , pp. 9-21

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Randomized, Blinded, Placebo‐ and Positive‐Controlled Crossover Study to Determine the Effect of Deferiprone on the QTc Interval in Healthy Subjects

Clinical Pharmacology In Drug Development,volume 7,issue 1 , Vol. 7, Iss. 1, 2018-01 , pp. 22-32

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Single‐ and Multiple‐Day Dosing Studies to Investigate High‐Dose Pharmacokinetics of Epelsiban and Its Metabolite, GSK2395448, in Healthy Female Volunteers

Clinical Pharmacology In Drug Development,volume 7,issue 1 , Vol. 7, Iss. 1, 2018-01 , pp. 33-43

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Pharmacokinetics, Safety, and Tolerability Following Single and Multiple Doses of Pibrentasvir in a First‐in‐Human Study

Clinical Pharmacology In Drug Development,volume 7,issue 1 , Vol. 7, Iss. 1, 2018-01 , pp. 44-52

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Acid Inhibitory Effect of a Combination of Omeprazole and Sodium Bicarbonate (CDFR0209) Compared With Delayed‐Release Omeprazole 40 mg Alone in Healthy Adult Male Subjects

Clinical Pharmacology In Drug Development,volume 7,issue 1 , Vol. 7, Iss. 1, 2018-01 , pp. 53-58

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

A Phase 1 Randomized, Placebo‐Controlled Study Assessing the Pharmacokinetics, Safety, and Tolerability of Retosiban in Healthy, Nonpregnant Japanese Subjects

Clinical Pharmacology In Drug Development,volume 7,issue 1 , Vol. 7, Iss. 1, 2018-01 , pp. 59-66

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Cardiac Safety of Rupatadine in a Single‐Ascending‐Dose and Multiple‐Ascending‐Dose Study in Healthy Japanese Subjects, Using Intensive Electrocardiogram Assessments—Comparison With the Previous White Caucasian Thorough QT Study

Clinical Pharmacology In Drug Development,volume 7,issue 1 , Vol. 7, Iss. 1, 2018-01 , pp. 67-76

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 13 item(s)